DermagridTM, a “first-in-class” wound healing product to treat diabetic foot ulcers.

DermagridTM

MxBiodevices is commercializing a patented injectable bioscaffold, “DermagridTM”, for the treatment of chronic dermal wounds including diabetic foot ulcers (DFUs), decubitus ulcers (bed sores), venous stasis ulcers (lower leg) and surgical adhesions.

before-and-after

Wound treated three times with Apligraf® and once with Regranex® without healing the wound.

Wound healed at 20 weeks after just 2 injections of DermagridTM.


Caution: DermagridTM is an investigational device, limited by law to investigational use only.